Immedica Pharma Us, Inc.

PA · United States · Reporting entity ID 100001081885

Total reported 2019–2025

$15.4M

#384 of 2,960 reporting companies — 0% of all reported industry payments

$1.05M in general payments across 2,889 records, plus $14.4M in research funding across 1,813 records.

How it breaks down

General payments $1,045,886

Research funding $14,388,837

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.